The global automated suturing devices market, valued at USD 3.2 billion in 2023, is on track for significant expansion, projected to reach USD 6.5 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 7.4% from 2023 to 2033, fueled by rising incidences of chronic diseases and an increasing shift towards minimally invasive surgeries (MIS) over traditional surgical procedures.
Automated suturing devices have become indispensable in modern surgical practices, providing precise and efficient suturing solutions for both open and minimally invasive surgeries. These devices are widely used across various medical specialties, including orthopedics, gynecology, ophthalmology, and cardiovascular surgery, delivering exceptional accuracy and minimizing human error during procedures.
Automated suturing devices help medical experts in suturing procedures during open and minimally invasive surgery. With the highest accuracy, these devices are used in applications such as orthopedics, gynecology, ophthalmology, and cardiovascular.
Automated suturing devices can be operated manually and automatically, both. They are also used in orthopedic surgeries, cardiovascular surgeries, and laparoscopy. Growing cases of chronic illnesses like cardiac arrest owing to unhealthy eating habits and hectic lifestyles are anticipated to drive the growth of the global market.
Expanding geriatric population, rising number of surgical procedures, growing cases of trauma, and increasing adoption of minimally invasive procedures are projected to accelerate the market growth in the coming time.
As per the World Health Organization, the number of people aged 60 years and more is estimated to outnumber children younger than five years by 2020, and in 2050, 80% of older people are estimated to be living in low and middle-income countries. It is likely to benefit the market in the coming time.
Increasing collaborations and agreements between players in the market can widen the market growth scope during the forecast period. In December 2019, Baxter International, Inc. inked a deal to acquire Seprafilm Adhesion Barrier and other associated assets from Sanofi. Such initiatives are projected to augment the market size significantly in the forthcoming period.
Key Takeaways from FMI’s Automated Suturing Devices Market Study:
- The global market is estimated to secure a CAGR of 7.4% with a valuation of US$ 6.5 billion by 2033.
- In the historical period, the global market secured a CAGR of 6.0% between 2018 and 2022.
- The United States is anticipated to dominate the global market by capturing a maximum share of 31.9% by 2033.
- With a share of 4.8%, Germany is significantly driving the global market during the forecast period.
- The automated suturing devices market in the U.S. will witness positive growth owing to rising prevalence of cardiovascular diseases and requirement for invasive procedures in the country.
- France will find lucrative opportunities during the forecast period as according to the Organization of Economic Cooperation and Development, approximately 148075 minimal invasive surgeries took place in France in 2018. The country also has presence of several manufacturers such as Guerbet, Sanofi, and others.
- Disposable automated suturing devices are expected to lead the product segment as they are cost-effective. Rising demand for laparoscopy and minimally invasive procedures are also encouraging demand for the same.
- Hospitals will exhibit high demand for automated suturing devices since they receive a higher footfall of patients on a daily basis.
Competition Analysis
Key players operating in the global market include Medtronic PLC, Boston Scientific, C.R. Bard Inc., Apollo Endosurgery, Endo Evolution LLC, LSI Solutions Inc., and SuturTek Inc.
Recent Developments in the Industry Include:
- In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused on integrating SynAR’s augmented reality of Surgical Theater with Medtronic’s StealthStation S8 surgical navigation system. In addition, Medtronic is likely to allow surgeons to increase their outputs by providing ingenious technologies to them
- In January 2022, Endomina, an endoscopic medical suture device developed an endo tools therapeutics, was approved by the United States Food and Drug Administration for endoscopic placement of sutures in the gastrointestinal tract in the adult population.\
Key Companies Profiled
Apollo Endosurgery; Medtronic Plc.; Boston Scientific Corporation; C.R Bard Inc.; EndoEvolution LLC; LSI Solutions Inc.; SuturTek Inc.
A Detailed Full Report
Automated Suturing Devices Market Segmentation
By Product:
- Reusable
- Disposable
By Application:
- Minimally Invasive Surgeries
- Open Surgeries
- Trauma Cases
By End Use:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
